RecruitingNot ApplicableNCT06134154

Safety and Efficacy of Carbon Dioxide Gas for Endoscopy

Safety and Efficacy of Carbon Dioxide Gas for Endoscopic Insufflation in Children


Sponsor

University of Alabama at Birmingham

Enrollment

350 participants

Start Date

Jan 24, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare the efficacy and safety of air versus carbon dioxide gas insufflation for endoscopy in children. The main question\[s\] it aims to answer are: •to determine safety of CO2 Assess patient comfort (abdominal pain, flatulence and bloating) with CO2 use when compared to air.


Eligibility

Min Age: 6 MonthsMax Age: 18 Years

Inclusion Criteria1

  • \- Infants and children 6 months to 18 years undergoing any upper endoscopy related procedure including but not limited to EGD/Colonoscopy, ERCP, EGD only, EUS, EGD with foreign body removal, Enteroscopy.

Exclusion Criteria4

  • Patients with American Society of Anesthesiology (ASA) Physical Status Classification System of 4 and above
  • Children with chronic lung disease,
  • Children who are wards of the state will be excluded.
  • Children needing language interpreting services that is not Spanish.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREndoscopic insufflation gas

Carbon dioxide gas versus air for endoscopic insufflation


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06134154


Related Trials